Skip to Main Content

Paper Details

Associations of Apixaban Dose With Safety and Effectiveness Outcomes in Patients With Atrial Fibrillation and Severe Chronic Kidney Disease.
Circulation
2
2023
Author NameAffiliation
Morgan E GramsJohns Hopkins Bloomberg School of Public Health
Morgan E GramsNew York University Grossman School of Medicine and Langone Health.
Morgan E GramsNew York University Grossman School of Medicine and Langone Health.
  • 1 - 3

Datasets

Release 1.2